Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review

August 2017 | 41 pages | ID: P097A81B65CEN
GlobalData

Abstracts

Pharmstandard (PHST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandard’s product portfolio includes drugs for treatments of cardio-vascular diseases, cancer, gastroenterology diseases, neurology diseases, diabetes, contagious diseases, growth hormone deficiency, metabolic disorders and other diseases. The company serves customers in The Commonwealth of Independent States (CIS) and Former Soviet Union (FSU) countries. Pharmstandard is headquartered in Dolgoprudny, Moscow Oblast, Russia.

Pharmstandard Key Recent Developments

Apr 29,2016: Pharmstandard reports FY2015 Audited IFRS Results
Apr 06,2016: Eisai and PharmStandard Sign Cooperation Agreements in Russia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Pharmstandard - Key Facts
Pharmstandard - Key Employees
Pharmstandard - Key Employee Biographies
Pharmstandard - Major Products and Services
Pharmstandard - History
Pharmstandard - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Pharmstandard - Business Description
Pharmstandard - Corporate Strategy
Pharmstandard - SWOT Analysis
SWOT Analysis - Overview
Pharmstandard - Strengths
Pharmstandard - Weaknesses
Pharmstandard - Opportunities
Pharmstandard - Threats
Pharmstandard - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Pharmstandard, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Pharmstandard, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Pharmstandard, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Apr 29, 2016: Pharmstandard reports FY2015 Audited IFRS Results
Apr 06, 2016: Eisai and PharmStandard Sign Cooperation Agreements in Russia

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Pharmstandard, Key Facts
Pharmstandard, Key Employees
Pharmstandard, Key Employee Biographies
Pharmstandard, Major Products and Services
Pharmstandard, History
Pharmstandard, Subsidiaries
Pharmstandard, Joint Venture
Pharmstandard, Key Competitors
Pharmstandard, Ratios based on current share price
Pharmstandard, Annual Ratios
Pharmstandard, Annual Ratios (Cont.1)
Pharmstandard, Annual Ratios (Cont.2)
Pharmstandard, Interim Ratios
Pharmstandard, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Pharmstandard, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Pharmstandard, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Pharmstandard, Performance Chart (2011 - 2015)
Pharmstandard, Ratio Charts
Pharmstandard, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Pharmstandard, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Valenta Farmatsevtika
Teva Pharmaceutical Industries Ltd
Stada Arzneimittel AG
Sotex Pharm Firm
Rosta ZAO
Pharmsynthez
Biosintez